title: Chronic eosinophilic leukaemia with FIP1L1-PDGFRA fusion and T6741 mutation that evolved from Langerhans cell histiocytosis with eosinophilia after chemotherapy.
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Ohnishi
authors.forename: Koji
authors.initials: K
authors.lastname: Kandabashi
authors.forename: Yoshiharu
authors.initials: Y
authors.lastname: Maeda
authors.forename: Machiko
authors.initials: M
authors.lastname: Kawamura
authors.forename: Takashi
authors.initials: T
authors.lastname: Watanabe
mesh_terms: D000328:Adult; D002908:Chronic Disease; D018450:Disease Progression; D004802:Eosinophilia / Q000150:complications / Q000188:drug therapy; D006646:Histiocytosis, Langerhans-Cell / Q000150:complications / Q000188:drug therapy; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000150:complications / Q000235:genetics*; D008297:Male; D009154:Mutation; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D020796:Receptor, Platelet-Derived Growth Factor alpha / Q000235:genetics*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D039221:mRNA Cleavage and Polyadenylation Factors / Q000235:genetics*
chemical_list: D015514:Oncogene Proteins, Fusion; D039221:mRNA Cleavage and Polyadenylation Factors; C479819:FIP1L1-PDGFRA fusion protein, human; D020796:Receptor, Platelet-Derived Growth Factor alpha